ArticleCell biochemistry and biophysics2026
Computational Identification of Paederia foetida Linn. Phytochemicals as Potential Inhibitors of Staphylococcus aureus Peptide Deformylase.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Staphylococcus aureus is a common cause of foodborne gastroenteritis and poses a growing public health concern due to its heat-stable enterotoxins and increasing antimicrobial resistance. In this study, an integrated in silico strategy was employed to investigate phytochemicals from Paederia foetida Linn. as potential inhibitors of S. aureus peptide deformylase (PDF), an essential bacterial enzyme absent in humans. LC-MS profiling of the hexane leaf extract tentatively annotated 139 phytochemicals, of which 110 structurally suitable compounds were selected for molecular docking. From these, the top 12 compounds possessing functional groups capable of forming stabilizing interactions within the catalytic pocket of PDF were shortlisted for further evaluation. Among them, the four best-performing compounds were 12-Epi-Scalaradial (- 8.7 ± 0.10 kcal/mol), Obliquine (- 8.6 ± 0.10 kcal/mol), Anisotine (- 8.5 ± 0.10 kcal/mol), and Deoxytubulosine (- 8.4 ± 0.10 kcal/mol), all of which demonstrated stronger predicted binding affinities than the native ligand MDB (- 8.2 ± 0.10 kcal/mol).To further assess the stability and binding behavior of these complexes, six independent 100 ns molecular dynamics simulations were performed. 12-Epi-Scalaradial exhibited a rigid and persistent binding pose stabilized by interactions with Gly110 and Leu112, suggesting a conformational restriction mechanism. In comparison, Obliquine and Deoxytubulosine maintained stable yet flexible interactions with key active-site residues. MM-PBSA analysis identified Deoxytubulosine (- 66 kJ/mol) and Obliquine (- 61 kJ/mol) as the most energetically favorable binders, whereas 12-Epi-Scalaradial appeared to contribute primarily to stabilization of the conformational dynamics of PDF. SwissADME predictions indicated favorable drug-likeness and gastrointestinal absorption for the prioritized compounds, although their limited aqueous solubility may require further formulation optimization. Overall, Deoxytubulosine and Obliquine emerged as promising natural candidates for further investigation as potential inhibitors of S. aureus PDF, which require experimental validation.
Indexed as
Identifiers
42270965What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.